These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 28333675)

  • 21. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
    Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new design for the review and appraisal of semi-solid dosage forms: Semi-solid Control Diagram (SSCD).
    Nardi-Ricart A; Linares MJ; Villca-Pozo F; Pérez-Lozano P; Suñé-Negre JM; Bachs-deMiquel L; Roig-Carreras M; Suñé-Pou M; Nofrerias-Roig I; García-Montoya E
    PLoS One; 2018; 13(9):e0201643. PubMed ID: 30192759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral transmucosal delivery of domperidone from immediate release films produced via hot-melt extrusion technology.
    Palem CR; Kumar Battu S; Maddineni S; Gannu R; Repka MA; Yamsani MR
    Pharm Dev Technol; 2013 Feb; 18(1):186-95. PubMed ID: 22881235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in film coating.
    Siepmann J; Bodmeier R; McGinity JW
    Int J Pharm; 2013 Dec; 457(2):361. PubMed ID: 24126036
    [No Abstract]   [Full Text] [Related]  

  • 26. APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW.
    Muhammad Sarfraz R; Bashir S; Mahmood A; Ahsan H; Riaz H; Raza H; Rashid Z; Atif Raza S; Asad Abrar M; Abbas K; Yasmeen T
    Acta Pol Pharm; 2017 Mar; 74(2):347-356. PubMed ID: 29624239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems.
    Kalogeras IM
    Eur J Pharm Sci; 2011 Apr; 42(5):470-83. PubMed ID: 21324354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of various analytical techniques in quality control of pharmaceutical excipients.
    Kumar M; Bhatia R; Rawal RK
    J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixing In a Compounding Pharmacy in the 21st Century.
    Standridge R
    Int J Pharm Compd; 2015; 19(6):479-84. PubMed ID: 26891562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-sized crystalline drug production by milling technology.
    Moribe K; Ueda K; Limwikrant W; Higashi K; Yamamoto K
    Curr Pharm Des; 2013; 19(35):6246-58. PubMed ID: 23470002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carrageenan as an efficient drug release modifier for ethylcellulose-coated pharmaceutical dosage forms.
    Siepmann F; Muschert S; Zach S; Leclercq B; Carlin B; Siepmann J
    Biomacromolecules; 2007 Dec; 8(12):3984-91. PubMed ID: 18039003
    [No Abstract]   [Full Text] [Related]  

  • 33. Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs.
    Simšič T; Planinšek O; Baumgartner A
    Acta Pharm; 2024 Jun; 74(2):177-199. PubMed ID: 38815202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix systems for oral drug delivery: Formulations and drug release.
    Vasvári G; Kalmár J; Veres P; Vecsernyés M; Bácskay I; Fehér P; Ujhelyi Z; Haimhoffer Á; Rusznyák Á; Fenyvesi F; Váradi J
    Drug Discov Today Technol; 2018 Jul; 27():71-80. PubMed ID: 30103866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oral films as perspective dosage form].
    Walicová V; Gajdziok J
    Ceska Slov Farm; 2016; 65(1):15-21. PubMed ID: 27118500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticulate strategies for effective delivery of poorly soluble therapeutics.
    Gokce EH; Ozyazici M; Souto EB
    Ther Deliv; 2010 Jul; 1(1):149-67. PubMed ID: 22816125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface responses and desirability functions to determine optimal granulation domains.
    Giry K; Viana M; Genty M; Wüthrich P; Chulia D
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1016-26. PubMed ID: 20818964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
    Zhang GG; Law D; Schmitt EA; Qiu Y
    Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.